AI-generated
May 3, 2026, 10:30
A New Era in Hemophilia A Prophylaxis – NEJM
The New England Journal of Medicine (NEJM) shared a post on X about a recent article by Maria Elisa Mancuso et al., adding:
”Original Article: Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors (phase 3 FRONTIER2 trial)
Science behind the Study: A Second Factor VIIIa Mimetic for Hemophilia A.”
Title: Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors
Authors: Maria Elisa Mancuso, Anthony K.C. Chan, Chandrakala Shanmukhaiah, Chuhl Joo Lyu, Joanna Zdziarska, Johnny Mahlangu, Lize F.D. van Vulpen, Pratima Chowdary, Renchi Yang, Steven R. Lentz, Tadashi Matsushita, Wan Hui Ong Clausen, Ilgiz Rakhmatullin, Johannes Oldenburg

Stay updated on all scientific advances with Hemostasis Today.
Anthony K C Chan
Chandrakala Shanmukhaiah
Chuhl Joo Lyu
Health
Hematology
Hemostasis
Hemostasis News
Hemostasis Today
Ilgiz Rakhmatullin
Joanna Zdziarska
Johannes Oldenburg
Johnny Mahlangu
Lize F.D. van Vulpen
Maria Elisa Mancuso
Medicine
NEJM
Pratima Chowdary
Renchi Yang
Steven R. Lentz
Tadashi Matsushita
Wan Hui Ong Clausen
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy